0001493152-24-029911.txt : 20240801 0001493152-24-029911.hdr.sgml : 20240801 20240801160514 ACCESSION NUMBER: 0001493152-24-029911 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240801 FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schellens Johannes Henricus Matthias CENTRAL INDEX KEY: 0002025872 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39717 FILM NUMBER: 241166526 MAIL ADDRESS: STREET 1: LAAG NIEUWKOOP 10 CITY: KOCKENGEN STATE: P7 ZIP: 3628 GC ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIXTE BIOTECHNOLOGY HOLDINGS, INC. CENTRAL INDEX KEY: 0001335105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 202903526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 BUSINESS PHONE: 310 203 2902 MAIL ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 FORMER COMPANY: FORMER CONFORMED NAME: SRKP 7 INC DATE OF NAME CHANGE: 20050803 3 1 ownership.xml X0206 3 2024-08-01 0 0001335105 LIXTE BIOTECHNOLOGY HOLDINGS, INC. LIXT 0002025872 Schellens Johannes Henricus Matthias 680 EAST COLORADO BOULEVARD, SUITE 180 PASADENA CA 91101 0 1 0 0 Chief Medical Officer Options to Purchase Common Stock 2.39 2024-07-01 2029-07-01 Common Stock 15000 D Effective July 1, 2024, under his Consulting Agreement with the Company, the Reporting Person was granted five-year options to purchase an aggregate of 15,000 shares of the Company's Common Stock vesting quarterly over a three year period commencing on the last day of each calendar quarter commencing September 30, 2024 until fully vested. On August 1, 2024, pursuant to the Consulting Agreement, the Reporting Person was appointed as the Company's Chief Medical Officer. /s/ Jan H.M. Schellens 2024-08-01